Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Personalized treatment for smoking cessation in primary care

Official title: A Multilevel Intervention to Personalize and Improve Tobacco Treatment in Primary Care (MOTIVATE)

Run by Washington University School of Medicine · NCT05846841 · Data updated 2026-11-12

This study is testing a personalized approach to help people quit smoking in primary care to see if it works better than the usual methods.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment850 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedSeptember 29, 2023
Main results expectedMarch 31, 2028
Study endsSeptember 30, 2028
Registry record updatedNovember 3, 2026
Trial IDNCT05846841 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are current smokers and willing to consider medication for smoking cessation.

Probably not a fit

Patients who have recently used smoking cessation medications or have contraindications for such treatments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a precision treatment intervention for smoking cessation, comparing its effectiveness to usual care in primary care settings. It utilizes personalized recommendations based on patients' clinical, genetic, and biomarker information to enhance treatment adherence and clinician prescribing practices. The study involves a 2-arm cluster randomized controlled trial with 50 clinicians and 800 eligible patients, aiming to assess the impact of precision treatment on smoking cessation success. The goal is to address gaps in both clinician and patient engagement with tobacco treatment.

Why it matters

Potential benefit: If successful, this approach could significantly improve smoking cessation rates among patients by providing tailored treatment options.

How similar studies have gone: Other studies have shown promise in using precision medicine approaches for smoking cessation, indicating potential for success in this novel intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Eligibility Criteria for Primary and Specialty Care Clinicians

* Clinician from participating clinic
* At least 18 years of age
* Can speak and understand English

Eligibility Criteria for Primary Care and Specialty Patients

Inclusion:

* Patient at participating clinic
* Age 18 years or older, inclusive
* Current smoking (cigarettes per day \>=5)
* Can speak and understand English
* Willing to consider medication to help reduce craving or smoking such as nicotine patch, lozenge, or varenicline

Exclusion:

* Active use of smoking cessation medication (within the past 30 days)
* Receipt of smoking cessation medication or prescription for smoking cessation medication (within the past 30 days)
* Having a contraindication for cNRT or varenicline (allergic reactions, current cardiac problems, pregnancy)

Where it's running

  • Washington University School of Medicine
    St Louis, Missouri, United States
    Recruiting

Study contacts

  • Principal investigator: Li-Shiun Chen, ScD, MD, MPH — Washington University School of Medicine
  • Study coordinator: Li-Shiun Chen, ScD, MD, MPH
  • Email: li-shiun@wustl.edu
  • Phone: 314-362-3932

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.